<DOC>
	<DOCNO>NCT00346320</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy delivers high dose radiation directly tumor may kill tumor cell cause less damage normal tissue . PURPOSE : This phase II trial study well radiation therapy work treat patient stage I stage II non-small cell lung cancer remove surgery .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Stage I Stage II Non-Small Cell Lung Cancer That Can Be Removed Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine local tumor control rate 2 year accelerate hypofractionated 3-dimensional , conformal radiotherapy patient inoperable T1-3 N0 M0 non-small cell lung cancer . Secondary - Determine toxicity regimen patient . - Determine rate regional distant disease recurrence patient . - Determine progression-free overall survival patient treat regimen . - Determine change pulmonary function treatment patient . - Assess quality life patient treatment . OUTLINE : This multicenter , prospective study . Patients undergo accelerate hypofractionated conformal radiotherapy 5 day week 3 week ( 15 dos ) absence disease progression unacceptable toxicity . Quality life assess baseline , week 3 radiotherapy , 1 month completion radiotherapy , every 4 month 1 year . After completion study treatment , patient follow periodically 5 year . PROJECTED ACCRUAL : A total 80 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm nonsmall cell lung cancer ( NSCLC ) Stage I II peripheral disease T1 , N0 , M0 T2 ( ≤ 5 cm ) , N0 , M0 T3 ( ≤ 5 cm , chest wall primary tumor ) , N0 , M0 No T2T3 primary tumor &gt; 5 cm T1T3 tumor mainstem bronchus involvement No T1T3 tumor lung apex ( i.e. , tumor position result irradiation brachial plexus prescribe dose ) Hilar mediastinal lymph node ≤ 1 cm consider N0 Any follow primary cancer type : Squamous cell carcinoma Adenocarcinoma Large cell carcinoma Bronchioloalveolar cell carcinoma Nonsmall cell carcinoma otherwise specify Underlying physiological medical condition prohibits surgery due low probability tolerate general anesthesia , operation , postoperative recovery period , removal adjacent functional lung ( i.e. , medically inoperable ) Cytologic specimen obtain brushing , wash , needle aspiration define lesion allow If sputum cytology alone use diagnosis , must confirm second specimen Must develop radiotherapy plan meet dosevolume constraint critical organ No ataxia telangiectasia PATIENT CHARACTERISTICS : ECOG performance status 02 Not pregnant nursing Able willing complete quality life questionnaire unless literate either English French ( i.e. , translator require comprehend question reply ) No active systemic , pulmonary , pericardial infection No previous malignancy except adequately treat nonmelanomatous skin cancer carcinoma situ cervix . Previous diagnosis cancer free recurrence metastasis ≥ 2 year , opinion treat physician , substantial risk recurrence allow ( include prior lung cancer ) PRIOR CONCURRENT THERAPY : No prior radiotherapy area primary tumor No prior concurrent chemotherapy immunotherapy tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>adenosquamous cell lung cancer</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
</DOC>